Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors
about
Cognitive training for improving executive function in chemotherapy-treated breast cancer survivorsChemotherapy-related cognitive impairment in older patients with cancerA Neurologist's Guide to TNF Biology and to the Principles behind the Therapeutic Removal of Excess TNF in DiseaseMechanisms of chemotherapy-induced behavioral toxicitiesPsychoneuroimmunology and cancer: a decade of discovery, paradigm shifts, and methodological innovationsChemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapyExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsOpening up the window into "chemobrain": a neuroimaging reviewAlterations in brain structure related to breast cancer and its treatment: chemotherapy and other considerations.Default mode network as a potential biomarker of chemotherapy-related brain injuryCognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?Physical activity, inflammation, and volume of the aging brainPrevalence, mechanisms, and management of cancer-related cognitive impairment.Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer TreatmentsClearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits.A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients.Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapyCytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future researchClinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adultsMeasuring sickness behavior in the context of pancreatic cancerAltered inflammatory activity associated with reduced hippocampal volume and more severe posttraumatic stress symptoms in Gulf War veterans.The relationship of serum macrophage inhibitory cytokine-1 levels with gray matter volumes in community-dwelling older individuals.The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.Yoga and self-reported cognitive problems in breast cancer survivors: a randomized controlled trial.Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort studyModerate Physical Activity Mediates the Association between White Matter Lesion Volume and Memory Recall in Breast Cancer SurvivorsHigher cardiorespiratory fitness levels are associated with greater hippocampal volume in breast cancer survivors.Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast CancerTrajectories of peripheral interleukin-6, structure of the hippocampus, and cognitive impairment over 14 years in older adults.A feasibility study exploring the role of pre-operative assessment when examining the mechanism of 'chemo-brain' in breast cancer patientsCognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.YOCAS©® Yoga Reduces Self-reported Memory Difficulty in Cancer Survivors in a Nationwide Randomized Clinical Trial: Investigating Relationships Between Memory and SleepDefault mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls.Elevated prefrontal myo-inositol and choline following breast cancer chemotherapy.Neuroimaging, cancer, and cognition: state of the knowledge.Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?Clinical features of brain metastases in breast cancer: an implication for hippocampal-sparing whole-brain radiation therapyNeuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.
P2860
Q24594173-6F41E15D-27AF-46B0-A581-A23E700AF9CDQ26747612-209A22B2-44BE-4DD7-9D51-A3D7B10A9451Q26801912-2199F23B-4FD0-4C39-B3FB-C42A256727B0Q26998870-93A12D63-5E42-4F24-AB7B-F277A142A9C5Q27007708-32CDDDDA-9525-44B8-A60F-199C06EA0755Q27011451-644C9A15-D39D-45AB-97DC-EF32AE0BA7FEQ28075692-AF27B516-72ED-49AD-8E09-49F49E3A4499Q30596880-ECE7F7AB-FEBF-4A2A-8899-A2DABED60467Q30664513-59E9BD81-5A2B-4991-A9B8-4E7B7FF17C64Q30830124-A18E4038-B60F-4653-8254-4E8F8F324467Q33729085-B48B3AED-D3DC-4F64-9F45-750FD5BC4863Q33827770-A29A2477-B5B7-4F19-923D-A9D0DB172A29Q33854977-465E9E82-7654-46AF-8255-05ED4560C928Q33907387-DD03183D-3505-49F9-B0BD-405B6514DBF5Q33926534-6C3EADAA-A14A-4003-A077-746C576FC4E7Q34110937-5D08CA41-E217-43CD-B122-C4090CC7A35AQ34503992-8055C9D4-AFFA-4DED-8033-2FED48B97777Q35034170-CFEAC8DA-CD37-4D30-AE6D-F0B50E611F4AQ35067446-0BE30658-239C-4190-9C27-A4AB3F5C08A3Q35164117-D472447C-78C9-464F-8063-2707BD288C1AQ35213470-C4EAA1FA-E89F-4221-89AE-FAE3387FD677Q35219605-A8F05CF4-3F46-4028-A4AD-36FF9AE3F9A6Q35388790-2448A79C-A7B7-443B-82C3-2FDDC7AA85FAQ35446931-9D60939A-F27E-41E4-A996-AB49F27050A6Q35513395-EE05505E-D7D5-4118-B79D-3409B21EC18EQ35775258-F5A7E70F-3849-4DA8-8063-021E5F66BB02Q35935819-0100CB11-D970-42C6-8343-D43893B63F86Q35996167-F910506F-28D2-4B31-8E8B-1F0F4FC76AA3Q36152838-7FA3511F-BB92-47AE-821A-2CFC0D759537Q36173493-546E3683-F1EF-4436-83D9-F0464CFC4098Q36478623-F12E2715-B62B-44EE-80B6-6E6FB13E6EF5Q36754399-245B5F80-5839-41FF-B4B4-40661036566AQ36901307-530558F9-F508-443E-9735-417015B9BF6EQ36945894-3F2765DF-C50F-4ED1-AC3B-C5DF486FF3EAQ37010580-CAAAAED4-9DB1-4D3E-AFF0-CB89B543EC07Q37064264-8CB2EA70-5302-4D24-9AC5-A0DC579551CEQ37292321-8693CB0E-ADA7-41A1-B35B-FD9E678FA948Q37431101-5D9DC300-F238-43D3-8FDA-2151080D5BD8Q37515347-62334E0C-9E8E-4BD3-A34D-4F94A3FA5006Q37540122-CEB4F754-BA85-49D1-B23A-EB52074B6C83
P2860
Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Reduced hippocampal volume and ...... reated breast cancer survivors
@en
type
label
Reduced hippocampal volume and ...... reated breast cancer survivors
@en
prefLabel
Reduced hippocampal volume and ...... reated breast cancer survivors
@en
P2093
P2860
P1476
Reduced hippocampal volume and ...... reated breast cancer survivors
@en
P2093
Della Koovakkattu
Firdaus S Dhabhar
Gary Morrow
Karen Mustian
Michelle Janelsins
Oxana Palesh
Shelli Kesler
P2860
P304
P356
10.1016/J.BBI.2012.05.017
P478
P577
2012-06-12T00:00:00Z